Interleukin-6 receptor antagonists tocilizumab and sarilumab, both used in the treatment of rheumatoid arthritis, may improve outcomes in critically ill patients with COVID-19, according to a study. The study, which appeared in medRxiv and is a preprint that has not yet been peer reviewed, reported outcomes of the Randomized, Embedded, Multifactorial Adaptive Platform Trial for … Continue reading Arthritis Drugs Tocilizumab and Sarilumab May Improve COVID-19 Survival